Stay updated with breaking news from Liquidia Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Liquidia will pursue final FDA approval for YUTREPIA™ (treprostinil) inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023
-- Enlivex Therapeutics said it completed enrollment of all 120 patients in a phase 2 trial of Allocetra in patients with sepsis, a life-threatening disease with no therapies approved by the US Food...
Liquidia will pursue final FDA approval for YUTREPIA™ inhalationLiquidia will immediately request that District Court set aside injunction tied to ‘793 patent MORRISVILLE, N.C., Dec. 20, 2023 ...
The biotech stock with the BofA's biggest upside already has approval for a drug that treats a rare kidney disease affecting up to 150,000 people in the U.S.
MORRISVILLE, N.C., Dec. 12, 2023 -- Liquidia Corporation announced today that it has priced an underwritten public offering of 3,491,620 shares of common stock at a public offering price of $7.16...